Neoplastic Plasma Cell - CISMeF

" /> Neoplastic Plasma Cell - CISMeF

CISMeF

chu

Neoplastic Plasma CellNCIt concept

Preferred Label : Neoplastic Plasma Cell;

Details

Origin ID

C37077;

UMLS CUI

C1514058;

Abnormal cell excluded by diseases
- IgM Monoclonal Gammopathy of Undetermined Significance, Not Otherwise Specified [NCIt concept]
Abnormal cell of diseases
- AESOP Syndrome [NCIt concept]
- Adrenal Gland Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Anaplastic Plasmacytoma [NCIt concept]
- Ann Arbor Stage I Lymphoplasmacytic Lymphoma [NCIt concept]
- Ann Arbor Stage II Lymphoplasmacytic Lymphoma [NCIt concept]
- Ann Arbor Stage III Lymphoplasmacytic Lymphoma [NCIt concept]
- Ann Arbor Stage IV Lymphoplasmacytic Lymphoma [NCIt concept]
- Brain Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Central Nervous System Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Chest Wall Solitary Plasmacytoma [NCIt concept]
- Colon Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Colorectal Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Cutaneous Plasmacytoma [NCIt concept]
- DS Stage I Multiple Myeloma [NCIt concept]
- DS Stage IA Multiple Myeloma [NCIt concept]
- DS Stage IB Multiple Myeloma [NCIt concept]
- DS Stage II Multiple Myeloma [NCIt concept]
- DS Stage IIA Multiple Myeloma [NCIt concept]
- DS Stage IIB Multiple Myeloma [NCIt concept]
- DS Stage III Multiple Myeloma [NCIt concept]
- DS Stage IIIA Multiple Myeloma [NCIt concept]
- DS Stage IIIB Multiple Myeloma [NCIt concept]
- Extramedullary Disease in Multiple Myeloma [NCIt concept]
- Extramedullary Disease in Multiple Myeloma Involving the Central Nervous System [NCIt concept]
- Extramedullary Disease in Multiple Myeloma Involving the Kidney [NCIt concept]
- Extramedullary Disease in Multiple Myeloma Involving the Leptomeninges [NCIt concept]
- Extramedullary Disease in Multiple Myeloma Involving the Liver [NCIt concept]
- Extramedullary Disease in Multiple Myeloma Involving the Lung [NCIt concept]
- Extramedullary Disease in Multiple Myeloma Involving the Skin [NCIt concept]
- Extramedullary Disease in Multiple Myeloma Involving the Spleen [NCIt concept]
- Extramedullary Disease in Multiple Myeloma Involving the Uterine Corpus [NCIt concept]
- Extraosseous Plasmacytoma [NCIt concept]
- Familial Waldenstrom Macroglobulinemia [NCIt concept]
- Gamma Heavy Chain Disease [NCIt concept]
- Gastric Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Gastrointestinal Tract Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Head and Neck Plasmacytoma [NCIt concept]
- ISS Stage I Multiple Myeloma [NCIt concept]
- ISS Stage II Multiple Myeloma [NCIt concept]
- ISS Stage III Multiple Myeloma [NCIt concept]
- IgM Monoclonal Gammopathy of Undetermined Significance, Plasma Cell Type [NCIt concept]
- Intestinal Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Liver Plasmacytoma [NCIt concept]
- Lung Plasmacytoma [NCIt concept]
- Lung Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Lymphoplasmacytic Lymphoma [NCIt concept]
- Lymphoplasmacytic Lymphoma by Ann Arbor Stage [NCIt concept]
- Monoclonal Gammopathy of Renal Significance [NCIt concept]
- Multiple Myeloma [NCIt concept]
- Multiple Myeloma Myeloma by DS Stage [NCIt concept]
- Multiple Myeloma Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Multiple Myeloma by ISS Stage [NCIt concept]
- Multiple Myeloma by RISS Stage [NCIt concept]
- Multiple Myeloma with CCND Family Translocation [NCIt concept]
- Multiple Myeloma with Hyperdiploidy [NCIt concept]
- Multiple Myeloma with MAF Family Translocation [NCIt concept]
- Multiple Myeloma with NSD2 Translocation [NCIt concept]
- Multiple Myeloma with Recurrent Genetic Abnormalities [NCIt concept]
- Multiple Myeloma with t(11;14)(q13;q32) [NCIt concept]
- Multiple Myeloma, Not Otherwise Specified [NCIt concept]
- Multiple Solitary Plasmacytoma of Bone [NCIt concept]
- Non-IgM Monoclonal Gammopathy of Undetermined Significance [NCIt concept]
- Non-Secretory Multiple Myeloma [NCIt concept]
- Osteosclerotic Multiple Myeloma [NCIt concept]
- POEMS Syndrome [NCIt concept]
- Plasma Cell Leukemia [NCIt concept]
- Plasma Cell Neoplasm [NCIt concept]
- Plasma Cell Neoplasm with Associated Paraneoplastic Syndrome [NCIt concept]
- Plasma Cell Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Plasmacytoma [NCIt concept]
- Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- RISS Stage I Multiple Myeloma [NCIt concept]
- RISS Stage II Multiple Myeloma [NCIt concept]
- RISS Stage III Multiple Myeloma [NCIt concept]
- Recurrent AL Amyloidosis [NCIt concept]
- Recurrent Extraosseous Plasmacytoma [NCIt concept]
- Recurrent Lymphoplasmacytic Lymphoma [NCIt concept]
- Recurrent Multiple Myeloma [NCIt concept]
- Recurrent Plasma Cell Leukemia [NCIt concept]
- Recurrent Plasma Cell Neoplasm [NCIt concept]
- Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Recurrent Primary Amyloidosis [NCIt concept]
- Recurrent Solitary Plasmacytoma [NCIt concept]
- Recurrent Waldenstrom Macroglobulinemia [NCIt concept]
- Refractory AL Amyloidosis [NCIt concept]
- Refractory Lymphoplasmacytic Lymphoma [NCIt concept]
- Refractory Multiple Myeloma [NCIt concept]
- Refractory Plasma Cell Leukemia [NCIt concept]
- Refractory Plasma Cell Neoplasm [NCIt concept]
- Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Refractory Primary Amyloidosis [NCIt concept]
- Refractory Waldenstrom Macroglobulinemia [NCIt concept]
- Secondary Plasma Cell Leukemia [NCIt concept]
- Sinonasal Plasmacytoma [NCIt concept]
- Small Intestinal Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Smoldering Multiple Myeloma [NCIt concept]
- Smoldering Waldenstrom Macroglobulinemia [NCIt concept]
- Solitary Plasmacytoma [NCIt concept]
- Solitary Plasmacytoma of Bone [NCIt concept]
- Splenic Lymphoplasmacytic Lymphoma [NCIt concept]
- Splenic Plasmacytoma [NCIt concept]
- TEMPI Syndrome [NCIt concept]
- Testicular Plasmacytoma [NCIt concept]
- Transformed Lymphoplasmacytic Lymphoma to Diffuse Large B-Cell Lymphoma [NCIt concept]
- Transformed Waldenstrom Macroglobulinemia to Diffuse Large B-Cell Lymphoma [NCIt concept]
- Triple-Class Refractory Multiple Myeloma [NCIt concept]
- Waldenstrom Macroglobulinemia [NCIt concept]
Semantic type(s)
- Cell [UMLS semantic type]
abnormal_cell_affected_by_chemical_or_drug
- Myeloma Ig Id-KLH Conjugate Vaccine [NCIt concept]
may_be_abnormal_cell_of_disease
- Advanced Marginal Zone Lymphoma [NCIt concept]
- Alpha Heavy Chain Disease [NCIt concept]
- Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Ann Arbor Stage I Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage I Nodal Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage I Splenic Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Ann Arbor Stage II Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage II Nodal Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage II Splenic Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage III Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Ann Arbor Stage III Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage III Nodal Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage III Splenic Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage IV Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Ann Arbor Stage IV Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage IV Nodal Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage IV Splenic Marginal Zone Lymphoma [NCIt concept]
- Bladder Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Borrelia Burgdoferi-Associated Primary Cutaneous Marginal Zone Lymphoproliferative Disorder [NCIt concept]
- Breast Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Campylobacter Jejuni-Associated Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Chlamydia Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Colon Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Endometrial Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Involving the Digestive System [NCIt concept]
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue by Ann Arbor Stage [NCIt concept]
- Gastric Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Head and Neck Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Heavy Chain Class-Switched Primary Cutaneous Marginal Zone Lymphoproliferative Disorder [NCIt concept]
- Helicobacter Pylori-Associated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- IgG-Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder [NCIt concept]
- IgG4-Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder [NCIt concept]
- IgM-Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder [NCIt concept]
- Kidney Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Lacrimal Drainage System Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Lacrimal Gland Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Lacrimal System Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Liver Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Lung Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Marginal Zone Lymphoma [NCIt concept]
- Marginal Zone Lymphoma by Ann Arbor Stage [NCIt concept]
- Nasopharyngeal Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Nodal Marginal Zone Lymphoma [NCIt concept]
- Nodal Marginal Zone Lymphoma by Ann Arbor Stage [NCIt concept]
- Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Parotid Gland Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Pediatric Nodal Marginal Zone Lymphoma [NCIt concept]
- Pleural Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Primary Cutaneous Marginal Zone Lymphoproliferative Disorder [NCIt concept]
- Rectal Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Recurrent Marginal Zone Lymphoma [NCIt concept]
- Recurrent Nodal Marginal Zone Lymphoma [NCIt concept]
- Recurrent Splenic Marginal Zone Lymphoma [NCIt concept]
- Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Refractory Marginal Zone Lymphoma [NCIt concept]
- Refractory Nodal Marginal Zone Lymphoma [NCIt concept]
- Refractory Splenic Marginal Zone Lymphoma [NCIt concept]
- Salivary Gland Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Splenic Marginal Zone Lymphoma [NCIt concept]
- Splenic Marginal Zone Lymphoma by Ann Arbor Stage [NCIt concept]
- Thymus Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Thyroid Gland Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients

Nous contacter.
21/10/2025

© Rouen University Hospital. Any partial or total use of this material must mention the source.